A carregar...
P09.32 High therapy compliance in patients treated with Optune® therapy does not depend on demographic data, stage of disease or treatment duration
Introduction: Optune is a novel treatment that is approved for the treatment of patients with newly diagnosed glioblastoma (GBM) and also for patients with recurrent high grade glioma (HGG). Alternating electric fields of low intensity (1-3 V / cm) and intermediate frequency (200 kHz) are delivered...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5464128/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.288 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|